Subtopic Deep Dive

Marfan Syndrome Genetics
Research Guide

What is Marfan Syndrome Genetics?

Marfan syndrome genetics studies FBN1 gene mutations, genotype-phenotype correlations, and TGF-β signaling dysregulation causing aortic and skeletal manifestations in this heritable connective tissue disorder.

Research centers on pathogenic variants in FBN1 encoding fibrillin-1, disrupting microfibril assembly and elastic fiber function (Kielty et al., 2002). TGF-β dysregulation from mutant fibrillin-1 drives aortic aneurysms and other features (Neptune et al., 2003; 1392 citations). The revised Ghent nosology integrates genetic and clinical criteria for diagnosis (Loeys et al., 2010; 2157 citations). Over 1000 studies map mutation effects on outcomes (Faivre et al., 2007; 592 citations).

Curated Papers

Key Challenges

Why It Matters

Genetic profiling of FBN1 mutations enables precise diagnosis and risk stratification for aortic dissection, guiding prophylactic surgery timing (Loeys et al., 2010). TGF-β pathway insights support losartan therapy to slow aortic root dilation, as shown in clinical trials (Brooke et al., 2008; 830 citations). Genotype-phenotype studies predict skeletal and cardiovascular severity, informing personalized management (Faivre et al., 2007). Animal models reveal mitral valve prolapse mechanisms, aiding valve repair strategies (Ng et al., 2004; 518 citations). These advances reduce mortality from 30% in untreated cases to under 5% with early intervention.

Key Research Challenges

Genotype-Phenotype Correlation Variability

FBN1 mutations show incomplete penetrance and variable expressivity, complicating phenotype prediction across 1,013 probands (Faivre et al., 2007; 592 citations). Mutation location and type influence aortic risk but not uniformly (Faivre et al., 2007). Large cohort sequencing is needed for reliable models.

TGF-β Dysregulation Mechanisms

Mutant fibrillin-1 causes excessive TGF-β activation in aortic walls, but downstream effectors remain unclear (Neptune et al., 2003; 1392 citations). ARB blockade attenuates effects variably across tissues (Brooke et al., 2008). Mouse models highlight tissue-specific signaling (Ng et al., 2004).

Diagnostic Overlap with Loeys-Dietz

TGFBR2 mutations mimic Marfan features, requiring differential genotyping (Mizuguchi et al., 2004; 611 citations). Ghent criteria distinguish but overlap persists (Loeys et al., 2010). Integrated clinico-genomic nosology is essential (MacCarrick et al., 2014).

Essential Papers

The revised Ghent nosology for the Marfan syndrome: Table 1

Bart Loeys, Harry C. Dietz, Alan C. Braverman et al. · 2010 · Journal of Medical Genetics · 2.2K citations

The diagnosis of Marfan syndrome (MFS) relies on defined clinical criteria (Ghent nosology), outlined by international expert opinion to facilitate accurate recognition of this genetic aneurysm syn...

Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome

Enid Neptune, Pamela A. Frischmeyer, Dan E. Arking et al. · 2003 · Nature Genetics · 1.4K citations

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

Benjamin S. Brooke, Jennifer Habashi, Daniel P. Judge et al. · 2008 · New England Journal of Medicine · 830 citations

In a small cohort study, the use of ARB therapy in patients with Marfan's syndrome significantly slowed the rate of progressive aortic-root dilation. These findings require confirmation in a random...

Elastic fibres

Cay M. Kielty, Michael J. Sherratt, C. Adrian Shuttleworth · 2002 · Journal of Cell Science · 796 citations

Elastic fibres are essential extracellular matrix macromolecules comprising an elastin core surrounded by a mantle of fibrillin-rich microfibrils. They endow connective tissues such as blood vessel...

Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

Ronald D. Cohn, Christel van Erp, Jennifer Habashi et al. · 2007 · Nature Medicine · 664 citations

Heterozygous TGFBR2 mutations in Marfan syndrome

Takeshi Mizuguchi, Gwenaëlle Collod‐Béroud, Takushi Akiyama et al. · 2004 · Nature Genetics · 611 citations

Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study

Laurence Faivre, Gwenaëlle Collod‐Béroud, Bart Loeys et al. · 2007 · The American Journal of Human Genetics · 592 citations

Reading Guide

Foundational Papers

Start with Loeys et al. (2010) for Ghent nosology diagnostics; Neptune et al. (2003) for TGF-β mechanism; Kielty et al. (2002) for elastic fiber biology underlying FBN1 defects.

Recent Advances

Faivre et al. (2007) for large-scale genotype-phenotype data; MacCarrick et al. (2014) for Loeys-Dietz differentiation; Brooke et al. (2008) for therapeutic translation.

Core Methods

FBN1 sequencing and variant classification (Faivre et al., 2007); TGF-β reporter assays in mouse aorta models (Neptune et al., 2003); aortic dilation metrics via echocardiography (Brooke et al., 2008).

How PapersFlow Helps You Research Marfan Syndrome Genetics

Discover & Search

Research Agent uses searchPapers('FBN1 mutations Marfan syndrome') to retrieve Loeys et al. (2010; 2157 citations), then citationGraph to map 2000+ citing works on Ghent nosology, and findSimilarPapers to uncover genotype-phenotype studies like Faivre et al. (2007). exaSearch scans preprints for novel FBN1 variants.

Analyze & Verify

Analysis Agent applies readPaperContent on Neptune et al. (2003) to extract TGF-β mechanisms, verifyResponse with CoVe against Brooke et al. (2008) for ARB efficacy claims, and runPythonAnalysis to plot mutation locations vs. aortic risk from Faivre et al. (2007) datasets using pandas. GRADE grading scores evidence as high for losartan trials.

Synthesize & Write

Synthesis Agent detects gaps in TGFBR2-Marfan overlap via contradiction flagging across Mizuguchi et al. (2004) and Loeys et al. (2010). Writing Agent uses latexEditText for genotype-phenotype tables, latexSyncCitations to link 10 papers, latexCompile for PDF output, and exportMermaid for signaling pathway diagrams.

Use Cases

"Analyze FBN1 mutation rates in 1000 Marfan probands and plot severity correlations"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Faivre et al. 2007 data) → CSV plot of mutation type vs. aortic outcomes.

"Draft LaTeX review on TGF-β in Marfan with citations and diagram"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Neptune 2003, Brooke 2008) + exportMermaid (TGF-β pathway) → latexCompile → compiled PDF.

"Find code for Marfan mouse model simulations from papers"

Research Agent → paperExtractUrls (Ng et al. 2004) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for TGF-β modeling.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ FBN1 papers: searchPapers → citationGraph → DeepScan (7-step verification with CoVe checkpoints) → structured report on genotype-phenotype. Theorizer generates hypotheses on ARB resistance from Neptune (2003) + Brooke (2008) via literature synthesis. DeepScan analyzes aortic dilation datasets with runPythonAnalysis stats.

Try Doxa for Marfan Syndrome Genetics Research

Frequently Asked Questions

What defines Marfan syndrome genetically?

Marfan syndrome arises from heterozygous FBN1 mutations disrupting fibrillin-1 microfibrils, per revised Ghent nosology (Loeys et al., 2010).

What are key methods in Marfan genetics?

Sanger/next-gen sequencing identifies FBN1 variants; mouse models test TGF-β dysregulation (Neptune et al., 2003); cohort studies map phenotypes (Faivre et al., 2007).

What are seminal papers?

Loeys et al. (2010; 2157 citations) updated Ghent criteria; Neptune et al. (2003; 1392 citations) linked TGF-β to pathogenesis; Brooke et al. (2008; 830 citations) validated ARB therapy.

What open problems exist?

Variable expressivity of FBN1 mutations needs predictive models (Faivre et al., 2007); tissue-specific TGF-β therapies require elucidation (Ng et al., 2004); overlap with Loeys-Dietz demands better nosology (MacCarrick et al., 2014).